Financials
- Market Capitalization 151.55 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.equilliumbio.com
- Headquarter Delaware, United States
- FIGI BBG00LSL8C10
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.97
Rapporto prezzo/fatturato
220.4
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3744 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.15 USD | -0.86% | -10.16% | -34.66% | -39.47% | 153.23 M USD | ||
| 3749 | LENZ LENZ Therapeutics, Inc. - Common Stock | 4.84 USD | +0.62% | +2.54% | -16.70% | -85.11% | 152.07 M USD | ||
| 3756 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.37 USD | -2.36% | -3.07% | +7.83% | -17.51% | 149.58 M USD | ||
| 3767 | ADCT ADC Therapeutics SA Common Shares | 1.15 USD | +2.68% | +18.56% | +3.60% | -64.62% | 146.82 M USD |